News

Pushing back against viruses with pandemic potential

Health Security Systems Australia (HSSA) is working with experts at the University of Melbourne at the Peter Doherty Institute for Infection and Immunity (Doherty Institute), The University of Queensland’s National Biologics Facility, and industry partner Biointelect Pty Ltd to develop a novel therapeutic platform technology to combat multiple viral pathogens with pandemic potential. (more…)

SABRE Alliance launched to align and leverage Australia’s biotech strengths

Defence launched the ‘Safeguarding Australia through Biotechnology Response and Engagement’ (SABRE) Alliance in July 2022. SABRE seeks to bring together biotech capabilities from Australia’s universities, research institutes, SMEs and manufacturers to work together to meet the needs of the Defence and national security sectors. (more…)

Recognition for high achievers

The achievements of individuals and teams across DMTC’s broad portfolio of programs have been recognised at the DMTC 2023 Annual Conference. Awards for Excellence were announced in seven categories. (more…)

HSSA – Working Lunch Webinar

WORKING LUNCH WEBINAR

7 October 2021

We asked industry leaders and technical experts, including Medicines Australia and Pfizer Australia, to join us to discuss the importance of the National Health Security Resilience Assessment, and the opportunity for Australia’s industrial and research sectors to ensure their contributions count.

Speakers included:

• Dr Leigh Farrell, Head Health Security Systems Australia
• Ms Elizabeth de Somer, Chief Executive Medicines Australia
• Ms Anne Harris, Managing Director Pfizer Australia & New Zealand

You can watch the recording here: